Literature DB >> 19063751

Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.

William E Tidyman1, Katherine A Rauen.   

Abstract

A class of developmental disorders caused by dysregulation of the Ras-induced mitogen-activated protein kinase (MAPK) cascade (the Ras-MAPK pathway) has emerged. Three of these disorders - Noonan, Costello and cardio-facio-cutaneous syndromes - have overlapping phenotypic features characterised by distinctive facial dysmorphia, cardiac defects, musculoskeletal and cutaneous abnormalities, and neurocognitive delay. The germline mutations associated with these disorders are in genes that encode proteins of the Ras-MAPK pathway. In vitro studies have determined that the overwhelming majority of these mutations result in increased signal transduction down the pathway, but usually to a lesser degree than somatic mutations in the same genes that are associated with cancer. The Ras-MAPK pathway is essential in the regulation of the cell cycle, differentiation, growth and senescence, so it is not surprising that germline mutations that affect its function have profound effects on development. Here we review the clinical consequences of the known molecular lesions associated with Noonan syndrome, Costello syndrome and cardio-facio-cutaneous syndrome, and explore possible therapeutic modalities for treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19063751     DOI: 10.1017/S1462399408000902

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  49 in total

1.  Ubiquitination: Added complexity in Ras and Rho family GTPase function.

Authors:  Michelle de la Vega; James F Burrows; James A Johnston
Journal:  Small GTPases       Date:  2011-07-01

Review 2.  Ras and Rap signaling in synaptic plasticity and mental disorders.

Authors:  Ruth L Stornetta; J Julius Zhu
Journal:  Neuroscientist       Date:  2010-04-29       Impact factor: 7.519

Review 3.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 4.  Deconstructing signal transduction pathways that regulate the actin cytoskeleton in dendritic spines.

Authors:  Peter Penzes; Michael E Cahill
Journal:  Cytoskeleton (Hoboken)       Date:  2012-03-12

5.  C4ST-1/CHST11-controlled chondroitin sulfation interferes with oncogenic HRAS signaling in Costello syndrome.

Authors:  Michael Klüppel; Payman Samavarchi-Tehrani; Kela Liu; Jeffrey L Wrana; Aleksander Hinek
Journal:  Eur J Hum Genet       Date:  2012-02-08       Impact factor: 4.246

6.  Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies.

Authors:  Katherine A Rauen; Anuradha Banerjee; W Robert Bishop; Jennifer O Lauchle; Frank McCormick; Martin McMahon; Teri Melese; Pamela N Munster; Sorena Nadaf; Roger J Packer; Judith Sebolt-Leopold; David H Viskochil
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-04-14       Impact factor: 3.908

Review 7.  New approaches for modelling sporadic genetic disease in the mouse.

Authors:  Elizabeth M C Fisher; Eva Lana-Elola; Sheona D Watson; George Vassiliou; Victor L J Tybulewicz
Journal:  Dis Model Mech       Date:  2009 Sep-Oct       Impact factor: 5.758

8.  Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.

Authors:  Talita M Marin; Kimberly Keith; Benjamin Davies; David A Conner; Prajna Guha; Demetrios Kalaitzidis; Xue Wu; Jessica Lauriol; Bo Wang; Michael Bauer; Roderick Bronson; Kleber G Franchini; Benjamin G Neel; Maria I Kontaridis
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

9.  Phosphorylation of Williams syndrome transcription factor by MAPK induces a switching between two distinct chromatin remodeling complexes.

Authors:  Hiroyuki Oya; Atsushi Yokoyama; Ikuko Yamaoka; Ryoji Fujiki; Masayoshi Yonezawa; Min-Young Youn; Ichiro Takada; Shigeaki Kato; Hirochika Kitagawa
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

10.  Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiation.

Authors:  Robert M Harmon; Cory L Simpson; Jodi L Johnson; Jennifer L Koetsier; Adi D Dubash; Nicole A Najor; Ofer Sarig; Eli Sprecher; Kathleen J Green
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.